This is a preview of subscription content, log in via an institution to check access.
Notes
The study was funded by LivaNova PLC.
Reference
Purser MF, et al. Expected Budget Impact and Health Outcomes of Expanded Use of Vagus Nerve Stimulation Therapy for Drug-Resistant Epilepsy. Advances in Therapy : 24 Aug 2018. Available from: URL: http://doi.org/10.1007/s12325-018-0775-0
Rights and permissions
About this article
Cite this article
Vagus nerve stimulation saves costs in drug-resistant epilepsy. PharmacoEcon Outcomes News 811, 36 (2018). https://doi.org/10.1007/s40274-018-5265-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-018-5265-8